B.i.t. Breast in translation 3.0

Bit 2026 aims to provide a brain-shaking, translational forum where clinicians and scientists explore the latest insights into metastatic dissemination, site-specific vulnerabilities, tumor heterogeneity, and the pre-metastatic niche. The program has the goal of inspiring the next generation of clinical scientists to think beyond algorithms and guidelines. in addition to scientific sessions, bit 2026 will also foster critical reflection on the culture of oncology and research, addressing themes such as ambition, visibility, role models and work–life balance. By blending science with discussions on the professional and human dimensions of our field, bit 2026 seeks to build a community committed to excellence, integrity, and innovation in metastatic breast cancer research and care.